Emily Itzel Pecero-García

Prof. Emily Itzel Pecero-García


Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 September 2025 in Microorganisms
Verified
Journal Article
Open access
PDF file
Emily Itzel Pecero-GarcíaEmily Itzel Pecero-García
Emily Itzel Pecero-García
JDJuan Carlos Domínguez-Hermosillo
Juan Carlos Domínguez-Hermosillo
YPYessica Sara Pérez-González
Yessica Sara Pérez-González
JNJuan Pablo Sánchez Navarro
Juan Pablo Sánchez Navarro
MAMauricio Alfredo Ambriz Alarcón
Mauricio Alfredo Ambriz Alarcón
Enrique Cervantes-PérezEnrique Cervantes-Pérez
Enrique Cervantes-Pérez
Despite advances in the understanding of Kaposi sarcoma (KS), research from resource-limited settings remains limited. This study aimed to estimate the proportion of epidemic visceral KS among Mexican people living with HIV (PLHIV) and to describe their clinical and biochemical characteristics. We included PLHIV with histopathologically confirmed KS who received care at the National Medical Center La Raza between March 2020 and February 2023. We calculated the prevalence of epidemic KS and epidemic visceral KS and analyzed clinical and biochemical variables potentially associated with visceral involvement. The prevalence of epidemic KS was 5.6%. Among these cases, 51.4% had visceral involvement, yielding an overall prevalence of 2.8%. Patients with epidemic visceral KS exhibited significantly higher rates of oral mucosal involvement and lower hemoglobin levels compared with those without visceral disease. These findings highlight the substantial burden of epidemic visceral KS in this population and should be confirmed in future studies with larger cohorts and robust designs aimed at identifying clinical and biochemical predictors of visceral involvement.